Targacept (TRGT +0.5%) creates a team of execs led by Chairman Mark Skaletsky to run the...

|By:, SA News Editor

Targacept (TRGT +0.5%) creates a team of execs led by Chairman Mark Skaletsky to run the biopharmaceutical company following the resignation of CEO Donald deBethizy after 12 years at the firm. Targacept laid off 65 workers in April in the wake of disappointing results for its TC-6987 diabetes and asthma drug in two mid-stage trials.